Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Population Pharmacokinetics and Dose Optimization of Ceftazidime and Imipenem in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Background: Ceftazidime and imipenem have been increasingly used to treat Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) due to their extended-spectrum covering <i>Pseudomonas aeruginosa</i>. This study aims to describe the population pharmacokinetic (PK) and pharm...

Full description

Bibliographic Details
Main Authors:	Thu-Minh Nguyen, Thu-Hue Ngo, Anh-Quan Truong, Dinh-Hoa Vu, Dinh-Chi Le, Ngan-Binh Vu, Tuyet-Nga Can, Hoang-Anh Nguyen, Thu-Phuong Phan, Françoise Van Bambeke, Céline Vidaillac, Quy-Chau Ngo
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Pharmaceutics
Subjects:	chronic obstructive pulmonary disease acute exacerbations ceftazidime imipenem dose optimization <i>Pseudomonas aeruginosa</i>
Online Access:	https://www.mdpi.com/1999-4923/13/4/456

Similar Items

Comparison the efficacy of ceftazidime and imipenem in treatment of neutropenic febrile due to chemotherapy in cancer patients
by: Zahra fotokian, et al.
Published: (2009-08-01)

Bacterial membrane vesicles from Acinetobacter baumannii induced by ceftazidime are more virulent than those induced by imipenem
by: Chun-Hsiang Chiu, et al.
Published: (2020-01-01)

Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test
by: MA Boroumand, et al.
Published: (2009-06-01)

Evaluation of Antimicrobial Resistance of Acinetobacter baumannii to Imipenem, Ciporofloxacin and Ceftazidime using E Test
by: MA Boroumand, et al.
Published: (2009-06-01)

Cepas de Pseudomonas spp. produtoras de metalo-betalactamase isoladas no Hospital Geral de Fortaleza Metallo-betalactamase producing Pseudomonas spp. strains isolated in the Hospital Geral de Fortaleza
by: Júlio César Nogueira Torres, et al.
Published: (2006-10-01)

Prevalency of imipenem-resistant bacterial strains isolated from hospital and accuracy of Iranian imipenem disc product
by: Ahmadi A, et al.
Published: (2015-03-01)

New Spectrophotometric Method for Estimation of Ceftazidime in pure and pharmaceutical dosage
by: Nibras Sabah Mohammed, et al.
Published: (2019-10-01)

Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical <i>Enterobacter roggenkampii</i> Isolate
by: Suruchi Nepal, et al.
Published: (2021-04-01)

In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase
by: Chunlei Wang, et al.
Published: (2021-09-01)

Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-05-01)

Successful Treatment of <i>Klebsiella pneumoniae</i> NDM Sepsis and Intestinal Decolonization with Ceftazidime/Avibactam Plus Aztreonam Combination in a Patient with TTP Complicated by SARSCoV-2 Nosocomial Infection
by: Francesco Perrotta, et al.
Published: (2021-04-01)

Estudo epidemiologico-molecular das infecções por pseudomonas aeruginosa resistente ao imipenem em pacientes hospitalizados
by: Cacci, Luciana Camila
Published: (2007)

Perbandingan Efektivitas Kombinasi Ceftazidime + Amikasin dan Ceftazidime sebagai Antibiotik Empiris Demam Neutropenia pada Keganasan
by: Agustinus William, et al.
Published: (2016-11-01)

Utility of the ceftazidime-imipenem antagonism test (CIAT) to detect and confirm the presence of inducible AmpC beta-lactamases among enterobacteriaceae
by: Vlademir Vicente Cantarelli, et al.

Ceftazidime as an empiric therapy for neonatal sepsis
by: Indrayady Indrayady, et al.
Published: (2021-08-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
by: Ying Han, et al.
Published: (2019-04-01)

<i>In Vitro</i> Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant <i>Enterobacterales</i> Isolates from South Korea
by: Taeeun Kim, et al.
Published: (2020-12-01)

Insights into the Periplasmic Proteins of <i>Acinetobacter baumannii</i> AB5075 and the Impact of Imipenem Exposure: A Proteomic Approach
by: Daniela Scribano, et al.
Published: (2019-07-01)

Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
by: Laura Martínez-García, et al.
Published: (2018-05-01)

Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem
by: Freitas Ana Lúcia Peixoto de, et al.
Published: (2002-01-01)

Antibiotic resistance and molecular typing of Pseudomonas aeruginosa: focus on imipenem
by: Ana Lúcia Peixoto de Freitas, et al.

In vitro activity of meropenem, imipenem, cefepime, cefoxitin and ciprofloxacin against multiresistant Klebsiella pneumoniae.
by: P Pruekprasert, et al.
Published: (2006-06-01)

Influence of the structure of ceftazidime on obtaining biologically active cellulosic bandage
by: Rodić-Grabovac Branka B., et al.
Published: (2017-01-01)

Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study
by: Rosario Cultrera, et al.
Published: (2020-09-01)

Diclofenac sodium and Imipenem action on rat intestinal mucosa: a biomechanical and histological study Ação do Diclofenaco de sódio e Imipenem na mucosa intestinal do rato: estudo biomecânico e histológico
by: Irio Gonçalves Junior, et al.
Published: (2012-02-01)

Imipenem Resistance Among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
by: AR Sharif, et al.
Published: (2010-06-01)

Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients
by: A Khorshidi, et al.
Published: (2010-06-01)

Direct Costs of Unnecessary Antibiotic Prescribing in Patients Administered Imipenem in the Emergency Department
by: Klein, Michael, et al.
Published: (2014)

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
by: Masoumeh Kiani, et al.
Published: (2021-06-01)

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by <i>Pseudomonas aeruginosa</i>
by: George L. Daikos, et al.
Published: (2021-09-01)

The Susceptibility Evaluation of Multiresistant Gram-Negative Bacilli to Meropenem and Imipenem
by: Nematollah Jonidi Jafari, et al.
Published: (2014-03-01)

Antimicrobial Synergy Testing: Comparing the Tobramycin and Ceftazidime Gradient Diffusion Methodology Used in Assessing Synergy in Cystic Fibrosis-Derived Multidrug-Resistant <i>Pseudomonas aeruginosa</i>
by: Ijeoma N. Okoliegbe, et al.
Published: (2021-08-01)

Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against <i>Acinetobacter </i>spp
by: Cristina Lasarte-Monterrubio, et al.
Published: (2021-02-01)

Assessment of the Appropriateness of Ceftazidime Use in a Tertiary Teaching Hospital, Northern Ethiopia
by: Gebremichael TG, et al.
Published: (2019-12-01)

Characterization of Imipenem Unsusceptible Pseudomonas Aeruginosa Isolates from Inpatients without Carbapenem Treatment
by: Gu Yi-hai, et al.
Published: (2013-03-01)

OXA-48-Mediated Ceftazidime-Avibactam Resistance Is Associated with Evolutionary Trade-Offs
by: Christopher Fröhlich, et al.
Published: (2019-03-01)

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation
by: Elnaz Sakhaiyan, et al.
Published: (2009-04-01)

Drug Utilization Evaluation of Imipenem in Patients Undergoing Bone Marrow Transplantation
by: Elnaz Sakhaiyan, et al.
Published: (2009-06-01)

Comparative Analysis of Three Methods for Determination of Imipenem Resistance in Pseudomonas aeruginosa
by: Tanaz Zabihi, et al.
Published: (2015-12-01)